| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 64 | 2021 | 563 | 5.550 |
Why?
|
| Amyloid beta-Peptides | 44 | 2020 | 190 | 5.340 |
Why?
|
| Amyloid Precursor Protein Secretases | 28 | 2021 | 59 | 3.940 |
Why?
|
| Amyloid beta-Protein Precursor | 42 | 2020 | 115 | 3.920 |
Why?
|
| Peptide Fragments | 15 | 2013 | 483 | 2.030 |
Why?
|
| Aspartic Acid Endopeptidases | 18 | 2020 | 47 | 1.490 |
Why?
|
| Endopeptidases | 15 | 2006 | 51 | 1.350 |
Why?
|
| Brain | 26 | 2021 | 2175 | 1.150 |
Why?
|
| Animals | 72 | 2022 | 20877 | 0.830 |
Why?
|
| Plaque, Amyloid | 7 | 2015 | 30 | 0.730 |
Why?
|
| Cholinesterase Inhibitors | 7 | 2006 | 58 | 0.700 |
Why?
|
| Neuroprotective Agents | 4 | 2018 | 317 | 0.680 |
Why?
|
| Lymph Nodes | 2 | 2018 | 258 | 0.680 |
Why?
|
| Amyloidosis | 2 | 2018 | 48 | 0.680 |
Why?
|
| Disease Models, Animal | 18 | 2018 | 2550 | 0.650 |
Why?
|
| Melatonin | 1 | 2018 | 39 | 0.630 |
Why?
|
| Membrane Proteins | 9 | 2006 | 617 | 0.580 |
Why?
|
| CHO Cells | 10 | 2013 | 161 | 0.550 |
Why?
|
| Presenilin-1 | 8 | 2015 | 28 | 0.550 |
Why?
|
| Neurons | 13 | 2014 | 881 | 0.510 |
Why?
|
| Retinal Pigment Epithelium | 3 | 2011 | 145 | 0.480 |
Why?
|
| Neurodegenerative Diseases | 5 | 2022 | 102 | 0.480 |
Why?
|
| Hippocampus | 5 | 2014 | 471 | 0.460 |
Why?
|
| Humans | 72 | 2022 | 68525 | 0.450 |
Why?
|
| Glycosylphosphatidylinositols | 3 | 2002 | 3 | 0.450 |
Why?
|
| Models, Biological | 12 | 2015 | 981 | 0.450 |
Why?
|
| Gene Expression Regulation | 9 | 2021 | 1293 | 0.450 |
Why?
|
| Molecular Sequence Data | 11 | 2013 | 1446 | 0.440 |
Why?
|
| Cricetinae | 9 | 2007 | 262 | 0.440 |
Why?
|
| MicroRNAs | 1 | 2017 | 447 | 0.430 |
Why?
|
| Enzyme Inhibitors | 4 | 2011 | 659 | 0.430 |
Why?
|
| Amino Acid Sequence | 10 | 2013 | 1082 | 0.420 |
Why?
|
| Memory, Short-Term | 3 | 2008 | 79 | 0.410 |
Why?
|
| Nerve Growth Factor | 3 | 2011 | 54 | 0.390 |
Why?
|
| Maze Learning | 4 | 2011 | 138 | 0.380 |
Why?
|
| Nerve Growth Factors | 3 | 2011 | 75 | 0.380 |
Why?
|
| Cholesterol, Dietary | 2 | 2008 | 22 | 0.380 |
Why?
|
| Insulysin | 2 | 2007 | 3 | 0.370 |
Why?
|
| Cholesterol | 3 | 2008 | 331 | 0.370 |
Why?
|
| Cholinergic Fibers | 2 | 2006 | 27 | 0.370 |
Why?
|
| DNA Damage | 3 | 2006 | 190 | 0.360 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2009 | 32 | 0.360 |
Why?
|
| Eye Proteins | 2 | 2011 | 160 | 0.350 |
Why?
|
| Eye | 1 | 2010 | 89 | 0.350 |
Why?
|
| Aging | 4 | 2021 | 911 | 0.340 |
Why?
|
| Dietary Fats | 2 | 2008 | 103 | 0.340 |
Why?
|
| Mice | 25 | 2021 | 8472 | 0.340 |
Why?
|
| Serpins | 2 | 2011 | 205 | 0.330 |
Why?
|
| Cells, Cultured | 10 | 2014 | 2673 | 0.330 |
Why?
|
| Physostigmine | 4 | 2013 | 14 | 0.320 |
Why?
|
| Basal Nucleus of Meynert | 2 | 2006 | 6 | 0.320 |
Why?
|
| Cytoplasm | 3 | 2007 | 155 | 0.310 |
Why?
|
| Polyisoprenyl Phosphates | 1 | 2007 | 8 | 0.310 |
Why?
|
| Breast Neoplasms | 1 | 2017 | 1533 | 0.310 |
Why?
|
| Biological Evolution | 1 | 2008 | 86 | 0.310 |
Why?
|
| Nerve Degeneration | 5 | 2010 | 134 | 0.310 |
Why?
|
| Fatty Acids | 1 | 2008 | 222 | 0.300 |
Why?
|
| Technology, Pharmaceutical | 2 | 2004 | 8 | 0.300 |
Why?
|
| Signal Transduction | 5 | 2015 | 2688 | 0.300 |
Why?
|
| Mice, Transgenic | 11 | 2018 | 1032 | 0.290 |
Why?
|
| Butyrylcholinesterase | 2 | 2005 | 9 | 0.280 |
Why?
|
| Promoter Regions, Genetic | 3 | 2008 | 614 | 0.280 |
Why?
|
| Receptors, Glucagon | 4 | 2014 | 6 | 0.270 |
Why?
|
| Indoles | 2 | 2021 | 146 | 0.270 |
Why?
|
| Membrane Microdomains | 2 | 2003 | 32 | 0.270 |
Why?
|
| Antibodies, Monoclonal | 2 | 2008 | 510 | 0.270 |
Why?
|
| Cell Compartmentation | 2 | 2004 | 41 | 0.270 |
Why?
|
| MAP Kinase Signaling System | 1 | 2006 | 247 | 0.270 |
Why?
|
| Cricetulus | 3 | 2013 | 98 | 0.270 |
Why?
|
| 5' Untranslated Regions | 2 | 2004 | 16 | 0.260 |
Why?
|
| Diet | 2 | 2010 | 513 | 0.260 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 9 | 2011 | 507 | 0.260 |
Why?
|
| Neural Pathways | 1 | 2006 | 323 | 0.250 |
Why?
|
| Memory Disorders | 4 | 2011 | 111 | 0.240 |
Why?
|
| Mutation | 5 | 2015 | 1213 | 0.240 |
Why?
|
| Uveitis | 1 | 2022 | 13 | 0.220 |
Why?
|
| Rats | 13 | 2020 | 5300 | 0.220 |
Why?
|
| Acetylcholine | 4 | 2008 | 64 | 0.210 |
Why?
|
| Environmental Exposure | 1 | 2004 | 269 | 0.210 |
Why?
|
| Protein Processing, Post-Translational | 4 | 2014 | 284 | 0.210 |
Why?
|
| Tacrine | 2 | 1998 | 2 | 0.210 |
Why?
|
| Deafness | 1 | 2022 | 64 | 0.200 |
Why?
|
| Guinea Pigs | 4 | 2003 | 124 | 0.200 |
Why?
|
| Macular Degeneration | 2 | 2014 | 75 | 0.200 |
Why?
|
| Oxidative Stress | 5 | 2010 | 718 | 0.200 |
Why?
|
| Epigenesis, Genetic | 3 | 2014 | 163 | 0.200 |
Why?
|
| Metalloendopeptidases | 3 | 2014 | 67 | 0.190 |
Why?
|
| Membrane Glycoproteins | 1 | 2003 | 370 | 0.190 |
Why?
|
| Estrogens | 1 | 2021 | 173 | 0.190 |
Why?
|
| Hearing Loss | 1 | 2022 | 154 | 0.180 |
Why?
|
| Response Elements | 3 | 2021 | 29 | 0.180 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2021 | 121 | 0.170 |
Why?
|
| Rats, Inbred F344 | 3 | 2008 | 104 | 0.170 |
Why?
|
| Protease Inhibitors | 5 | 2007 | 76 | 0.170 |
Why?
|
| 3-Hydroxyacyl CoA Dehydrogenases | 1 | 1998 | 5 | 0.170 |
Why?
|
| Protein Sorting Signals | 1 | 1998 | 11 | 0.170 |
Why?
|
| Brain Chemistry | 3 | 2010 | 173 | 0.160 |
Why?
|
| Enzyme Activation | 3 | 2007 | 791 | 0.160 |
Why?
|
| Carrier Proteins | 2 | 1998 | 597 | 0.150 |
Why?
|
| Inflammation Mediators | 2 | 2021 | 244 | 0.150 |
Why?
|
| Apolipoproteins E | 2 | 2015 | 92 | 0.150 |
Why?
|
| Hypercholesterolemia | 3 | 2010 | 86 | 0.150 |
Why?
|
| Aflatoxins | 4 | 1989 | 6 | 0.140 |
Why?
|
| Golgi Apparatus | 3 | 1993 | 75 | 0.140 |
Why?
|
| Down Syndrome | 2 | 2008 | 119 | 0.140 |
Why?
|
| Neoplasm Invasiveness | 1 | 2017 | 369 | 0.140 |
Why?
|
| Endosomes | 2 | 2014 | 45 | 0.140 |
Why?
|
| Base Sequence | 9 | 2012 | 1015 | 0.140 |
Why?
|
| Heat-Shock Proteins | 1 | 1996 | 69 | 0.140 |
Why?
|
| Cell Line | 6 | 2011 | 1752 | 0.140 |
Why?
|
| Endothelin-Converting Enzymes | 2 | 2014 | 15 | 0.140 |
Why?
|
| Antibody Specificity | 2 | 2008 | 98 | 0.140 |
Why?
|
| Cattle | 3 | 2010 | 475 | 0.130 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2011 | 626 | 0.130 |
Why?
|
| Presenilin-2 | 1 | 2015 | 6 | 0.130 |
Why?
|
| Molecular Weight | 3 | 2003 | 358 | 0.130 |
Why?
|
| Cerebral Cortex | 5 | 2009 | 415 | 0.130 |
Why?
|
| Pyrrolidonecarboxylic Acid | 1 | 2014 | 3 | 0.130 |
Why?
|
| Solubility | 5 | 2001 | 134 | 0.130 |
Why?
|
| Protein Transport | 3 | 2006 | 280 | 0.120 |
Why?
|
| Cell Proliferation | 2 | 2017 | 1173 | 0.120 |
Why?
|
| 5' Flanking Region | 2 | 2004 | 8 | 0.120 |
Why?
|
| Incretins | 1 | 2014 | 14 | 0.120 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2006 | 231 | 0.120 |
Why?
|
| Female | 13 | 2021 | 38015 | 0.120 |
Why?
|
| Cycloheximide | 2 | 2010 | 50 | 0.120 |
Why?
|
| Proteolysis | 1 | 2014 | 97 | 0.120 |
Why?
|
| Macromolecular Substances | 2 | 2003 | 122 | 0.110 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 756 | 0.110 |
Why?
|
| Plasminogen Inactivators | 1 | 1992 | 1 | 0.110 |
Why?
|
| Organelles | 1 | 1992 | 18 | 0.110 |
Why?
|
| Transcription Factors | 3 | 2006 | 753 | 0.110 |
Why?
|
| Amyloidogenic Proteins | 1 | 2012 | 4 | 0.110 |
Why?
|
| Mutagens | 2 | 1989 | 18 | 0.110 |
Why?
|
| Gene-Environment Interaction | 1 | 2012 | 31 | 0.110 |
Why?
|
| Cell Death | 4 | 2009 | 329 | 0.110 |
Why?
|
| Mutant Proteins | 1 | 2012 | 45 | 0.110 |
Why?
|
| Peptide Hydrolases | 2 | 2003 | 82 | 0.110 |
Why?
|
| Age Factors | 4 | 2012 | 1860 | 0.110 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2011 | 219 | 0.100 |
Why?
|
| Environment | 3 | 2012 | 115 | 0.100 |
Why?
|
| PC12 Cells | 6 | 2004 | 36 | 0.100 |
Why?
|
| Biological Assay | 1 | 2011 | 88 | 0.100 |
Why?
|
| Male | 16 | 2021 | 37281 | 0.100 |
Why?
|
| Retina | 2 | 2010 | 252 | 0.100 |
Why?
|
| Risk Factors | 5 | 2012 | 5719 | 0.090 |
Why?
|
| Brain Injuries | 1 | 2014 | 268 | 0.090 |
Why?
|
| Hyperlipoproteinemia Type II | 1 | 2010 | 4 | 0.090 |
Why?
|
| Mitochondria | 2 | 2010 | 643 | 0.090 |
Why?
|
| Base Composition | 4 | 2004 | 22 | 0.090 |
Why?
|
| Axonal Transport | 2 | 2006 | 9 | 0.090 |
Why?
|
| Homocysteine | 2 | 2010 | 26 | 0.090 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2010 | 32 | 0.090 |
Why?
|
| Body Fluids | 1 | 2010 | 41 | 0.090 |
Why?
|
| Glucagon-Like Peptide-1 Receptor | 4 | 2014 | 20 | 0.090 |
Why?
|
| Nutrition Therapy | 1 | 2010 | 21 | 0.090 |
Why?
|
| Vitreous Body | 1 | 2010 | 26 | 0.090 |
Why?
|
| Cholecalciferol | 1 | 2011 | 143 | 0.090 |
Why?
|
| Aqueous Humor | 1 | 2010 | 51 | 0.090 |
Why?
|
| Drug Discovery | 1 | 2011 | 94 | 0.090 |
Why?
|
| Longevity | 1 | 2010 | 59 | 0.090 |
Why?
|
| Permeability | 1 | 2009 | 131 | 0.090 |
Why?
|
| Mice, Knockout | 5 | 2021 | 1692 | 0.090 |
Why?
|
| Central Nervous System | 1 | 2010 | 107 | 0.090 |
Why?
|
| Tocopherols | 1 | 2008 | 7 | 0.090 |
Why?
|
| Epithelial Cells | 1 | 2011 | 431 | 0.090 |
Why?
|
| Chelation Therapy | 1 | 2009 | 17 | 0.090 |
Why?
|
| Cytoprotection | 1 | 2009 | 39 | 0.090 |
Why?
|
| Guanidines | 1 | 1988 | 32 | 0.080 |
Why?
|
| Aluminum | 1 | 2008 | 21 | 0.080 |
Why?
|
| Immunohistochemistry | 5 | 2006 | 1174 | 0.080 |
Why?
|
| Chelating Agents | 1 | 2009 | 47 | 0.080 |
Why?
|
| Reversal Learning | 1 | 2008 | 7 | 0.080 |
Why?
|
| Coconut Oil | 1 | 2008 | 3 | 0.080 |
Why?
|
| Neurofibrillary Tangles | 1 | 2008 | 7 | 0.080 |
Why?
|
| Mice, Inbred BALB C | 1 | 2010 | 532 | 0.080 |
Why?
|
| Hybridomas | 1 | 2008 | 25 | 0.080 |
Why?
|
| Tumor Cells, Cultured | 5 | 2006 | 852 | 0.080 |
Why?
|
| Microscopy, Video | 1 | 2008 | 27 | 0.080 |
Why?
|
| Immunoglobulin Isotypes | 1 | 2008 | 28 | 0.080 |
Why?
|
| DNA | 4 | 1990 | 597 | 0.080 |
Why?
|
| Orientation | 1 | 2008 | 31 | 0.080 |
Why?
|
| Plant Oils | 1 | 2008 | 31 | 0.080 |
Why?
|
| Encephalitis | 1 | 2008 | 43 | 0.080 |
Why?
|
| DNA, Z-Form | 1 | 2008 | 1 | 0.080 |
Why?
|
| Protein Precursors | 2 | 2003 | 105 | 0.080 |
Why?
|
| Blotting, Western | 5 | 2006 | 954 | 0.080 |
Why?
|
| Venoms | 2 | 2009 | 6 | 0.080 |
Why?
|
| Cholesterol, HDL | 1 | 2008 | 112 | 0.080 |
Why?
|
| Metals | 1 | 2009 | 100 | 0.080 |
Why?
|
| Vitamins | 1 | 2008 | 134 | 0.080 |
Why?
|
| Silver Staining | 1 | 2007 | 11 | 0.080 |
Why?
|
| Triglycerides | 1 | 2008 | 184 | 0.080 |
Why?
|
| Fluoresceins | 1 | 2007 | 31 | 0.080 |
Why?
|
| Down-Regulation | 2 | 2006 | 447 | 0.080 |
Why?
|
| Swine | 1 | 2009 | 672 | 0.080 |
Why?
|
| Cell Line, Tumor | 4 | 2006 | 1849 | 0.080 |
Why?
|
| Substrate Specificity | 1 | 2007 | 234 | 0.070 |
Why?
|
| Receptor, trkA | 1 | 2006 | 13 | 0.070 |
Why?
|
| Lovastatin | 1 | 2007 | 78 | 0.070 |
Why?
|
| Cell Adhesion Molecules, Neuron-Glia | 1 | 2006 | 1 | 0.070 |
Why?
|
| Autolysis | 1 | 2006 | 2 | 0.070 |
Why?
|
| Genes, cdc | 1 | 2006 | 5 | 0.070 |
Why?
|
| Cognition Disorders | 1 | 2010 | 342 | 0.070 |
Why?
|
| Hydrolysis | 2 | 1999 | 144 | 0.070 |
Why?
|
| Neuroblastoma | 3 | 2006 | 109 | 0.070 |
Why?
|
| Immunotherapy | 1 | 2008 | 212 | 0.070 |
Why?
|
| Dopamine | 1 | 2009 | 474 | 0.070 |
Why?
|
| Fluorescent Dyes | 1 | 2007 | 191 | 0.070 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2006 | 175 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2011 | 1745 | 0.070 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2008 | 689 | 0.070 |
Why?
|
| Binding Sites | 2 | 2004 | 631 | 0.070 |
Why?
|
| Parkinson Disease | 1 | 2009 | 272 | 0.070 |
Why?
|
| Molecular Biology | 2 | 2004 | 31 | 0.070 |
Why?
|
| Amyloid | 1 | 2006 | 39 | 0.070 |
Why?
|
| Introns | 2 | 2004 | 68 | 0.070 |
Why?
|
| Hot Temperature | 2 | 1996 | 152 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 5 | 2012 | 2790 | 0.060 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2004 | 27 | 0.060 |
Why?
|
| Inflammation | 3 | 2022 | 1030 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2006 | 331 | 0.060 |
Why?
|
| Stereoisomerism | 3 | 2013 | 169 | 0.060 |
Why?
|
| Steroid Hydroxylases | 1 | 2004 | 19 | 0.060 |
Why?
|
| Consensus Sequence | 1 | 2004 | 20 | 0.060 |
Why?
|
| Transcription Initiation Site | 1 | 2004 | 11 | 0.060 |
Why?
|
| Transcription, Genetic | 2 | 2021 | 562 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2004 | 32 | 0.060 |
Why?
|
| Restriction Mapping | 1 | 2004 | 85 | 0.060 |
Why?
|
| Apolipoproteins | 1 | 2004 | 51 | 0.060 |
Why?
|
| Secretory Vesicles | 1 | 2004 | 6 | 0.060 |
Why?
|
| ADAM17 Protein | 1 | 2004 | 28 | 0.060 |
Why?
|
| Phorbol Esters | 1 | 2004 | 37 | 0.060 |
Why?
|
| L-Lactate Dehydrogenase | 2 | 2006 | 67 | 0.060 |
Why?
|
| Exons | 1 | 2004 | 122 | 0.060 |
Why?
|
| Thalidomide | 1 | 2004 | 24 | 0.060 |
Why?
|
| Acetylcholinesterase | 2 | 2002 | 19 | 0.060 |
Why?
|
| Cues | 1 | 2008 | 654 | 0.060 |
Why?
|
| ADAM Proteins | 1 | 2004 | 53 | 0.060 |
Why?
|
| Learning | 1 | 2005 | 186 | 0.060 |
Why?
|
| Cloning, Molecular | 1 | 2004 | 357 | 0.060 |
Why?
|
| Glucagon | 1 | 2003 | 22 | 0.060 |
Why?
|
| Hydroxamic Acids | 1 | 2004 | 84 | 0.060 |
Why?
|
| Dipeptides | 1 | 2004 | 89 | 0.060 |
Why?
|
| Alcohol Drinking | 1 | 2010 | 805 | 0.060 |
Why?
|
| Cell Survival | 4 | 2014 | 901 | 0.060 |
Why?
|
| Drug Design | 1 | 2004 | 107 | 0.060 |
Why?
|
| Genomics | 1 | 2004 | 167 | 0.060 |
Why?
|
| Protein Subunits | 1 | 2003 | 99 | 0.060 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2003 | 38 | 0.060 |
Why?
|
| Autopsy | 1 | 2002 | 56 | 0.060 |
Why?
|
| Postmenopause | 1 | 2003 | 92 | 0.060 |
Why?
|
| Dependovirus | 1 | 2022 | 34 | 0.050 |
Why?
|
| Prefrontal Cortex | 1 | 2008 | 639 | 0.050 |
Why?
|
| Protein Kinase C | 2 | 2004 | 270 | 0.050 |
Why?
|
| Transduction, Genetic | 1 | 2022 | 81 | 0.050 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2001 | 618 | 0.050 |
Why?
|
| Neoplasm Proteins | 1 | 2004 | 307 | 0.050 |
Why?
|
| Biology | 1 | 2002 | 14 | 0.050 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2022 | 126 | 0.050 |
Why?
|
| Estradiol | 1 | 2003 | 176 | 0.050 |
Why?
|
| tau Proteins | 2 | 2014 | 61 | 0.050 |
Why?
|
| Culture Media, Conditioned | 2 | 1998 | 78 | 0.050 |
Why?
|
| Gene Transfer Techniques | 1 | 2022 | 173 | 0.050 |
Why?
|
| Genetic Vectors | 1 | 2022 | 311 | 0.050 |
Why?
|
| Transfection | 5 | 2001 | 782 | 0.050 |
Why?
|
| Phenanthrolines | 1 | 2001 | 5 | 0.050 |
Why?
|
| Pepstatins | 1 | 2001 | 3 | 0.050 |
Why?
|
| Estrogen Receptor alpha | 1 | 2021 | 65 | 0.050 |
Why?
|
| Neuroprotection | 1 | 2021 | 28 | 0.050 |
Why?
|
| Detergents | 1 | 2001 | 34 | 0.050 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2022 | 199 | 0.050 |
Why?
|
| Subcellular Fractions | 1 | 2001 | 92 | 0.050 |
Why?
|
| Drug Delivery Systems | 1 | 2003 | 236 | 0.050 |
Why?
|
| Androstadienes | 1 | 2000 | 41 | 0.050 |
Why?
|
| HEK293 Cells | 1 | 2021 | 326 | 0.050 |
Why?
|
| Caspases | 1 | 2001 | 194 | 0.050 |
Why?
|
| Genetic Therapy | 1 | 2022 | 291 | 0.050 |
Why?
|
| Analysis of Variance | 3 | 2008 | 1039 | 0.050 |
Why?
|
| HeLa Cells | 2 | 1999 | 237 | 0.050 |
Why?
|
| Rivastigmine | 1 | 2020 | 6 | 0.050 |
Why?
|
| Clinical Trials as Topic | 1 | 2004 | 848 | 0.050 |
Why?
|
| Caspase 3 | 1 | 2001 | 233 | 0.050 |
Why?
|
| Sulfur Radioisotopes | 3 | 1999 | 11 | 0.050 |
Why?
|
| RNA, Antisense | 1 | 1999 | 25 | 0.050 |
Why?
|
| Phosphoinositide Phospholipase C | 1 | 1999 | 1 | 0.050 |
Why?
|
| Phosphatidylinositol Diacylglycerol-Lyase | 1 | 1999 | 6 | 0.050 |
Why?
|
| Immunosuppressive Agents | 1 | 2004 | 514 | 0.050 |
Why?
|
| Intracellular Membranes | 1 | 1999 | 86 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2021 | 295 | 0.040 |
Why?
|
| Type C Phospholipases | 1 | 1999 | 67 | 0.040 |
Why?
|
| Apoptosis | 1 | 2006 | 1640 | 0.040 |
Why?
|
| Endoplasmic Reticulum | 1 | 1999 | 148 | 0.040 |
Why?
|
| Drosophila | 1 | 1998 | 37 | 0.040 |
Why?
|
| Microbodies | 1 | 1998 | 60 | 0.040 |
Why?
|
| Biological Transport | 1 | 1998 | 210 | 0.040 |
Why?
|
| Chromaffin Granules | 1 | 1998 | 2 | 0.040 |
Why?
|
| Recombinant Proteins | 3 | 2012 | 742 | 0.040 |
Why?
|
| Cell Fractionation | 2 | 1999 | 34 | 0.040 |
Why?
|
| Cell Membrane | 3 | 1998 | 523 | 0.040 |
Why?
|
| Aged | 4 | 2014 | 14842 | 0.040 |
Why?
|
| DNA Replication | 3 | 1989 | 167 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 3 | 2006 | 290 | 0.040 |
Why?
|
| Leupeptins | 1 | 1997 | 23 | 0.040 |
Why?
|
| Iodine Radioisotopes | 2 | 1998 | 119 | 0.040 |
Why?
|
| Kinetics | 2 | 2003 | 1047 | 0.040 |
Why?
|
| Reactive Oxygen Species | 2 | 2010 | 499 | 0.040 |
Why?
|
| Aflatoxin B1 | 4 | 1989 | 5 | 0.040 |
Why?
|
| Stroke | 1 | 2009 | 2161 | 0.030 |
Why?
|
| Software | 1 | 1998 | 418 | 0.030 |
Why?
|
| Shock | 1 | 1995 | 28 | 0.030 |
Why?
|
| Lysosomes | 2 | 1993 | 136 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2005 | 2083 | 0.030 |
Why?
|
| Up-Regulation | 2 | 2008 | 682 | 0.030 |
Why?
|
| Immunoblotting | 3 | 2004 | 254 | 0.030 |
Why?
|
| Endocytosis | 1 | 1995 | 113 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2009 | 7028 | 0.030 |
Why?
|
| Cholera Toxin | 1 | 1994 | 30 | 0.030 |
Why?
|
| DNA, Viral | 3 | 1989 | 114 | 0.030 |
Why?
|
| Receptors, Lipoxin | 1 | 2014 | 3 | 0.030 |
Why?
|
| Receptors, Formyl Peptide | 1 | 2014 | 4 | 0.030 |
Why?
|
| Lipoxins | 1 | 2014 | 4 | 0.030 |
Why?
|
| Docosahexaenoic Acids | 1 | 2014 | 12 | 0.030 |
Why?
|
| Lipoxygenase | 1 | 2014 | 13 | 0.030 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1994 | 138 | 0.030 |
Why?
|
| Antioxidants | 1 | 1996 | 304 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1995 | 376 | 0.030 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 1993 | 36 | 0.030 |
Why?
|
| Nuclear Proteins | 2 | 2006 | 271 | 0.030 |
Why?
|
| Protease Nexins | 1 | 1992 | 8 | 0.030 |
Why?
|
| Peptides | 2 | 2009 | 455 | 0.030 |
Why?
|
| Proteoglycans | 1 | 1993 | 103 | 0.030 |
Why?
|
| Mice, Inbred Strains | 2 | 2003 | 181 | 0.030 |
Why?
|
| Neurofibrils | 1 | 1992 | 2 | 0.030 |
Why?
|
| Receptors, Muscarinic | 1 | 2013 | 44 | 0.030 |
Why?
|
| Sulfates | 1 | 1992 | 28 | 0.030 |
Why?
|
| alpha-Synuclein | 1 | 2013 | 28 | 0.030 |
Why?
|
| Polymorphism, Genetic | 2 | 2004 | 301 | 0.030 |
Why?
|
| Choline O-Acetyltransferase | 2 | 2008 | 30 | 0.030 |
Why?
|
| Receptors, Nicotinic | 1 | 2013 | 41 | 0.030 |
Why?
|
| Aprotinin | 1 | 1992 | 55 | 0.030 |
Why?
|
| Escherichia coli | 3 | 1989 | 368 | 0.030 |
Why?
|
| Interleukin-1beta | 1 | 2013 | 88 | 0.030 |
Why?
|
| Chromosomes, Artificial, Yeast | 1 | 2012 | 16 | 0.030 |
Why?
|
| Receptors, Notch | 1 | 2012 | 15 | 0.030 |
Why?
|
| Plasmids | 2 | 1994 | 258 | 0.030 |
Why?
|
| Gene Knock-In Techniques | 1 | 2012 | 35 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2006 | 1663 | 0.030 |
Why?
|
| Tight Junctions | 1 | 2011 | 25 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2012 | 166 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2012 | 137 | 0.030 |
Why?
|
| DNA, Complementary | 1 | 2012 | 251 | 0.030 |
Why?
|
| Time Factors | 2 | 2014 | 4655 | 0.030 |
Why?
|
| Receptors, Cell Surface | 1 | 1992 | 248 | 0.030 |
Why?
|
| Substantia Innominata | 1 | 1991 | 3 | 0.030 |
Why?
|
| Membrane Potentials | 1 | 2011 | 200 | 0.030 |
Why?
|
| Tretinoin | 1 | 2011 | 92 | 0.020 |
Why?
|
| NFI Transcription Factors | 1 | 2011 | 6 | 0.020 |
Why?
|
| N-Methylaspartate | 1 | 1991 | 59 | 0.020 |
Why?
|
| Retinaldehyde | 1 | 2011 | 115 | 0.020 |
Why?
|
| Cognitive Dysfunction | 1 | 2014 | 176 | 0.020 |
Why?
|
| Viral Proteins | 1 | 2011 | 149 | 0.020 |
Why?
|
| Rodentia | 1 | 2010 | 27 | 0.020 |
Why?
|
| Electron Transport | 1 | 2010 | 37 | 0.020 |
Why?
|
| Receptors, Lipoprotein | 1 | 2010 | 11 | 0.020 |
Why?
|
| Oxidative Phosphorylation | 1 | 2010 | 54 | 0.020 |
Why?
|
| Spain | 1 | 2010 | 34 | 0.020 |
Why?
|
| Avitaminosis | 1 | 2010 | 3 | 0.020 |
Why?
|
| Bone and Bones | 1 | 2011 | 145 | 0.020 |
Why?
|
| DNA-Binding Proteins | 2 | 2004 | 700 | 0.020 |
Why?
|
| Vitamin E | 1 | 2010 | 55 | 0.020 |
Why?
|
| Protective Agents | 1 | 2010 | 36 | 0.020 |
Why?
|
| Receptors, Dopamine | 1 | 1990 | 119 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2014 | 1548 | 0.020 |
Why?
|
| Point Mutation | 1 | 2010 | 97 | 0.020 |
Why?
|
| Bacteriophages | 1 | 1989 | 24 | 0.020 |
Why?
|
| Cholesterol, LDL | 1 | 2010 | 161 | 0.020 |
Why?
|
| Acetaldehyde | 1 | 1989 | 18 | 0.020 |
Why?
|
| Guanidine | 1 | 1988 | 7 | 0.020 |
Why?
|
| Chromosomes, Mammalian | 1 | 2008 | 8 | 0.020 |
Why?
|
| 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 1 | 2009 | 22 | 0.020 |
Why?
|
| Mice, Neurologic Mutants | 1 | 2008 | 23 | 0.020 |
Why?
|
| DNA, Single-Stranded | 2 | 1987 | 41 | 0.020 |
Why?
|
| Energy Intake | 1 | 2010 | 123 | 0.020 |
Why?
|
| Calbindins | 1 | 2008 | 23 | 0.020 |
Why?
|
| S100 Calcium Binding Protein G | 1 | 2008 | 21 | 0.020 |
Why?
|
| Middle Aged | 3 | 2014 | 21119 | 0.020 |
Why?
|
| Mesencephalon | 1 | 2009 | 41 | 0.020 |
Why?
|
| Prosencephalon | 1 | 2008 | 38 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 2008 | 134 | 0.020 |
Why?
|
| Trisomy | 1 | 2008 | 47 | 0.020 |
Why?
|
| beta-Galactosidase | 1 | 1988 | 88 | 0.020 |
Why?
|
| Cell Hypoxia | 1 | 2009 | 92 | 0.020 |
Why?
|
| Brain Infarction | 1 | 2009 | 54 | 0.020 |
Why?
|
| Discrimination Learning | 1 | 2008 | 45 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2009 | 176 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2010 | 222 | 0.020 |
Why?
|
| Receptors, LDL | 1 | 2008 | 72 | 0.020 |
Why?
|
| Odorants | 1 | 2008 | 52 | 0.020 |
Why?
|
| Biomarkers | 1 | 2014 | 1593 | 0.020 |
Why?
|
| Rabbits | 1 | 2008 | 509 | 0.020 |
Why?
|
| Psychomotor Performance | 1 | 2008 | 213 | 0.020 |
Why?
|
| YY1 Transcription Factor | 1 | 2006 | 6 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2010 | 1199 | 0.020 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2006 | 39 | 0.020 |
Why?
|
| Linear Models | 1 | 2008 | 521 | 0.020 |
Why?
|
| Cystathionine beta-Synthase | 1 | 2006 | 1 | 0.020 |
Why?
|
| Extracellular Space | 1 | 2006 | 121 | 0.020 |
Why?
|
| Cognition | 1 | 2010 | 512 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2006 | 137 | 0.020 |
Why?
|
| Tartrates | 1 | 2005 | 2 | 0.020 |
Why?
|
| Incidence | 1 | 2010 | 1582 | 0.020 |
Why?
|
| Cell Count | 1 | 2006 | 248 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2006 | 189 | 0.020 |
Why?
|
| Serine | 1 | 2005 | 99 | 0.020 |
Why?
|
| Tumor Necrosis Factor Decoy Receptors | 1 | 2004 | 1 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2006 | 420 | 0.020 |
Why?
|
| Precipitin Tests | 2 | 1995 | 88 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2006 | 492 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2005 | 371 | 0.020 |
Why?
|
| Cholesterol 24-Hydroxylase | 1 | 2004 | 1 | 0.020 |
Why?
|
| Hydroxycholesterols | 1 | 2004 | 10 | 0.020 |
Why?
|
| Orphan Nuclear Receptors | 1 | 2004 | 5 | 0.020 |
Why?
|
| Cholestanetriol 26-Monooxygenase | 1 | 2004 | 8 | 0.020 |
Why?
|
| Liver X Receptors | 1 | 2004 | 8 | 0.020 |
Why?
|
| Neurobiology | 1 | 2004 | 9 | 0.020 |
Why?
|
| Receptors, Steroid | 1 | 2004 | 13 | 0.020 |
Why?
|
| Benzothiazoles | 1 | 2004 | 14 | 0.020 |
Why?
|
| Transcription Factor AP-2 | 1 | 2004 | 9 | 0.020 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2004 | 73 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2010 | 7264 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2004 | 60 | 0.020 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2004 | 66 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2004 | 89 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2004 | 207 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2011 | 1070 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2004 | 191 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2004 | 167 | 0.010 |
Why?
|
| Cytokines | 1 | 2008 | 866 | 0.010 |
Why?
|
| Thiazoles | 1 | 2004 | 95 | 0.010 |
Why?
|
| Models, Neurological | 1 | 2004 | 136 | 0.010 |
Why?
|
| Oligodendroglia | 1 | 2004 | 107 | 0.010 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2003 | 17 | 0.010 |
Why?
|
| Adenoviridae | 1 | 2004 | 295 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2004 | 161 | 0.010 |
Why?
|
| Glioma | 2 | 1995 | 140 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2010 | 3256 | 0.010 |
Why?
|
| Administration, Cutaneous | 1 | 2003 | 56 | 0.010 |
Why?
|
| DNA Primers | 1 | 2003 | 302 | 0.010 |
Why?
|
| Fetus | 1 | 2003 | 157 | 0.010 |
Why?
|
| Sex Factors | 1 | 2006 | 1265 | 0.010 |
Why?
|
| Kidney | 2 | 1999 | 945 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2002 | 322 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2003 | 567 | 0.010 |
Why?
|
| Astrocytes | 1 | 2004 | 270 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 710 | 0.010 |
Why?
|
| Sequence Analysis, Protein | 1 | 2001 | 16 | 0.010 |
Why?
|
| Iron | 1 | 2003 | 197 | 0.010 |
Why?
|
| Cell-Free System | 1 | 2000 | 43 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2010 | 2222 | 0.010 |
Why?
|
| Genotype | 1 | 2003 | 785 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2010 | 1085 | 0.010 |
Why?
|
| Drosophila melanogaster | 1 | 2001 | 80 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2001 | 381 | 0.010 |
Why?
|
| Oligopeptides | 1 | 2000 | 152 | 0.010 |
Why?
|
| Uridine Diphosphate N-Acetylglucosamine | 1 | 1999 | 2 | 0.010 |
Why?
|
| Radioisotope Dilution Technique | 1 | 1999 | 14 | 0.010 |
Why?
|
| Glucosamine | 1 | 1999 | 8 | 0.010 |
Why?
|
| Inositol | 1 | 1999 | 11 | 0.010 |
Why?
|
| Mannose | 1 | 1999 | 9 | 0.010 |
Why?
|
| Choline | 1 | 1999 | 14 | 0.010 |
Why?
|
| Carbohydrate Sequence | 1 | 1999 | 45 | 0.010 |
Why?
|
| K562 Cells | 1 | 1999 | 44 | 0.010 |
Why?
|
| Tritium | 1 | 1999 | 101 | 0.010 |
Why?
|
| Tubulin | 1 | 1999 | 60 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2000 | 411 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2000 | 222 | 0.010 |
Why?
|
| Doxycycline | 1 | 1999 | 49 | 0.010 |
Why?
|
| Cysteine | 1 | 1999 | 112 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2003 | 1737 | 0.010 |
Why?
|
| Polyethylene Glycols | 1 | 1999 | 149 | 0.010 |
Why?
|
| Models, Chemical | 1 | 1999 | 155 | 0.010 |
Why?
|
| Azirines | 1 | 1998 | 1 | 0.010 |
Why?
|
| Adrenal Medulla | 1 | 1998 | 5 | 0.010 |
Why?
|
| Photoaffinity Labels | 1 | 1998 | 7 | 0.010 |
Why?
|
| Biotinylation | 1 | 1998 | 27 | 0.010 |
Why?
|
| Trypsin | 1 | 1998 | 64 | 0.010 |
Why?
|
| Cross-Linking Reagents | 1 | 1998 | 80 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2003 | 1851 | 0.010 |
Why?
|
| Parasympathomimetics | 1 | 1997 | 13 | 0.010 |
Why?
|
| Carbachol | 1 | 1997 | 34 | 0.010 |
Why?
|
| Nucleic Acid Conformation | 2 | 1987 | 92 | 0.010 |
Why?
|
| Methylamines | 1 | 1995 | 4 | 0.010 |
Why?
|
| Chloroquine | 1 | 1995 | 21 | 0.010 |
Why?
|
| Alkaline Phosphatase | 1 | 1995 | 71 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 1995 | 149 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2003 | 3702 | 0.010 |
Why?
|
| Cold Temperature | 1 | 1995 | 90 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1995 | 282 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1995 | 282 | 0.010 |
Why?
|
| Placenta | 1 | 1995 | 101 | 0.010 |
Why?
|
| Mutagenesis | 1 | 1994 | 60 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2003 | 4843 | 0.010 |
Why?
|
| GTP-Binding Proteins | 1 | 1994 | 231 | 0.010 |
Why?
|
| Chromatography, Gel | 1 | 1991 | 79 | 0.010 |
Why?
|
| Polyribosomes | 1 | 1991 | 24 | 0.010 |
Why?
|
| Methionine | 1 | 1991 | 36 | 0.010 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 1991 | 50 | 0.010 |
Why?
|
| Autoradiography | 1 | 1991 | 94 | 0.010 |
Why?
|
| Rats, Inbred Strains | 1 | 1991 | 532 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 1991 | 181 | 0.010 |
Why?
|
| Poly A | 1 | 1990 | 14 | 0.010 |
Why?
|
| Pituitary Gland | 1 | 1990 | 29 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1990 | 95 | 0.010 |
Why?
|
| Brain Neoplasms | 1 | 1994 | 371 | 0.010 |
Why?
|
| Nucleic Acid Heteroduplexes | 1 | 1989 | 7 | 0.010 |
Why?
|
| Receptors, Dopamine D2 | 1 | 1990 | 109 | 0.010 |
Why?
|
| Cytosine Nucleotides | 1 | 1989 | 2 | 0.010 |
Why?
|
| Coliphages | 1 | 1989 | 6 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 1993 | 1034 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 1989 | 159 | 0.010 |
Why?
|
| Guanine | 1 | 1987 | 21 | 0.000 |
Why?
|
| Manganese | 1 | 1987 | 26 | 0.000 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1987 | 37 | 0.000 |
Why?
|
| Magnesium | 1 | 1987 | 110 | 0.000 |
Why?
|
| DNA, Bacterial | 1 | 1987 | 150 | 0.000 |
Why?
|
| Templates, Genetic | 1 | 1985 | 9 | 0.000 |
Why?
|
| Chemical Phenomena | 1 | 1985 | 62 | 0.000 |
Why?
|
| Chemistry | 1 | 1985 | 45 | 0.000 |
Why?
|
| Epoxy Compounds | 1 | 1985 | 20 | 0.000 |
Why?
|
| Hydrogen Bonding | 1 | 1985 | 66 | 0.000 |
Why?
|